Clinico-investigation on epidemiological study in 119 Indian cases of melasma

Background: Melasma, a multifactorial disease, constitutes the most common facial melanosis in Indian population. Methods: 119 cases of melasma aged 18 years or above were enrolled. Detailed history, examination and laboratory investigations were done. Results: 20 (16.8%) were males and 99 (83.2%) females. Mean age was 35.25 years. Disease duration was more than 1 year in 102 (85.7%), 6 months to 1 year in 10 (8.4%) and less than 6 months in 7 (5.9%). 22 (18.49%) had occupation-related increased duration of sun-exposure 19 (86.3%) or heat-exposure 3 (13.6%). 79 (66.4%) had skin type IV, 26 (21.8%) type III, 14 (11.8%) type V. Centrofacial was commonest distribution pattern in 87 (73.1%), malar in 30 (25.2%), mandibular in 2 (1.7%). Mean duration of daily sun-exposure was 53.36 minutes (male-124.75, female-38.94). Mean Melasma Area and Severity Index (MASI) score was 11.602. There was significant association between MASI and skin type (p<0.001). Other etiological factors were: Oral Contraceptive Pills (OCPs) use in 17 (17.17%), melasma during pregnancy in 39 (39.4%), family history of melasma in 24 (20.2%), hair dye use in 66 (55.5%), cosmetics use in 19 (16%), mustard oil use in 31 (26.1%), mustard oil along with other oil(s)’ use in 39 (32.8%). Laboratory investigations revealed anemia in 60 (50.42%), dyslipidemia in 73 (61.34%), abnormal thyroid function test in 26 (21.85%), serum vitamin B12 deficiency in 35 (29.4%) and vitamin D deficiency in 94 (79%). Conclusions: Higher skin phototypes should be cautious about general measures and associated risk factors (hair dye/oils, cosmetics). Increased daily sun-exposure, OCPs use, pregnancy, thyroid disorders are risk factors. Housewives and indoor occupations should be advised physical sunscreens for protection against infra-red radiation. Anemia, dyslipidemia, thyroid dysfunction, vitamin D and B12 levels can be assessed although their exact role in perpetuating/precipitating melasma needs further studies

[1]  T. Vogt,et al.  [Melasma : An update on the clinical picture, treatment, and prevention]. , 2017, Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete.

[2]  Heber Anandan,et al.  Clinico-epidemiological Study of Patients with Melasma in a Tertiary Care Hospital-A Prospective Study , 2017 .

[3]  Ritu Agrawal,et al.  Melasma: Through the eye of a dermoscope , 2016 .

[4]  A. Kılıç,et al.  Etiopathogenetic factors, thyroid functions and thyroid autoimmunity in melasma patients , 2015, Postepy dermatologii i alergologii.

[5]  W. Roberts,et al.  Pollution as a risk factor for the development of melasma and other skin disorders of facial hyperpigmentation ‑ is there a case to be made? , 2015, Journal of drugs in dermatology : JDD.

[6]  S. Chang,et al.  Gene Expression Profiling in Melasma in Korean Women , 2014, Dermatology.

[7]  H. Miot,et al.  Risk factors for facial melasma in women: a case–control study , 2014, The British journal of dermatology.

[8]  H. Miot,et al.  Melasma: a clinical and epidemiological review* , 2014, Anais brasileiros de dermatologia.

[9]  L. Azulay-Abulafia,et al.  Epidemiology of melasma in Brazilian patients: a multicenter study , 2014, International journal of dermatology.

[10]  G. Kadhe,et al.  A Cross-Sectional, Multicentric Clinico-Epidemiological Study of Melasma in India , 2014, Dermatology and Therapy.

[11]  H. Miot,et al.  Clinical patterns and epidemiological characteristics of facial melasma in Brazilian women , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.

[12]  H. Y. Kang,et al.  Defective barrier function in melasma skin , 2011, Journal of the European Academy of Dermatology and Venereology : JEADV.

[13]  Vaneeta M. Sheth,et al.  Melasma: a comprehensive update: part I. , 2011, Journal of the American Academy of Dermatology.

[14]  J. Ortonne,et al.  Transcriptional profiling shows altered expression of wnt pathway- and lipid metabolism-related genes as well as melanogenesis-related genes in melasma. , 2011, The Journal of investigative dermatology.

[15]  S. Rathi,et al.  MELASMA: A CLINICO-EPIDEMIOLOGICAL STUDY OF 312 CASES , 2011, Indian journal of dermatology.

[16]  A. D. de Craen,et al.  Serum triiodothyronine levels and inflammatory cytokine production capacity , 2011, AGE.

[17]  C. Guinot,et al.  Aggravating factors for melasma: a prospective study in 197 Tunisian patients , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.

[18]  P. Puri,et al.  Melasma in men: a clinical, aetiological and histological study , 2009, Journal of the European Academy of Dermatology and Venereology : JEADV.

[19]  C. Kusminski,et al.  The Road From Discovery to Clinic: Adiponectin as a Biomarker of Metabolic Status , 2009, Clinical pharmacology and therapeutics.

[20]  M. Guerre-Millo.  Adiponectin: an update. , 2008, Diabetes & metabolism.

[21]  B. Khaitan,et al.  Pigmentary disorders in India. , 2007, Dermatologic clinics.

[22]  H. Kang,et al.  PPAR‐gamma agonist, ciglitazone, increases pigmentation and migration of human melanocytes , 2007, Experimental dermatology.

[23]  N. Martin,et al.  Interactions between the melanocortin system and the hypothalamo–pituitary–thyroid axis , 2006, Peptides.

[24]  P. Puri,et al.  Melasma in Indian males. , 2003, Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.].

[25]  S. Sohn,et al.  Melasma: histopathological characteristics in 56 Korean patients , 2002, The British journal of dermatology.

[26]  A. Pandya,et al.  Disorders of hyperpigmentation. , 2000, Dermatologic clinics.

[27]  P. Grimes.  Melasma. Etiologic and therapeutic considerations. , 1995, Archives of dermatology.

[28]  T. Hamilton,et al.  Topical retinoic acid (tretinoin) for melasma in black patients. A vehicle-controlled clinical trial. , 1994, Archives of dermatology.

[29]  G. Mullin,et al.  Cutaneous signs of thyroid disease. , 1986, American family physician.

[30]  E. A. González,et al.  Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma. , 1985, Journal of Clinical Endocrinology and Metabolism.

[31]  S. Gupta,et al.  Contact Hwersensitaity to Mustard Khal and Mustard Oil. , 1985, Indian journal of dermatology, venereology and leprology.

[32]  A. Cox,et al.  Epidermal changes in vitamin B 12 deficiency. , 1973, Archives of dermatology.

[33]  L. E. Gaul.  CONTACT DERMATITIS FROM SYNTHETIC OIL OF MUSTARD. , 1964, Archives of dermatology.